TRDC002

· C Ray Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TRDC002, covering 2026-04-15 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: Study of TRDC002 in the Diagnosis of Patients With PSMA-positive Prostate Cancer [Phase 1]